0
We Serve

Clinical Diagnostics

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve
What we do

Select Capabilities

All Capabilities

Pricing Strategy

Precise pricing is critical to realizing maximum adoption and market value. DeciBio takes a multi-pronged approach to triangulate optimal price points for your products and services.
View

Surveys / Trackers / ATUs

The precision medicine market is dynamic, and technological and clinical disruption can cause it to pivot on a dime. Track your markets closely, distinguish signal from noise, and respond accordingly.
View

Technology Application Identification

Your tech is going to change the world -- but how? DeciBio’s team of life scientists knows why and how your technology creates value, and we’ll help you find exactly where to focus to demonstrate that to customers and the broader market.
View
Impact

Selected Work

All Work
Clinical Diagnostics
RNA-based Oncology Biomarker Market Landscape
A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings
View
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping
Clinical Diagnostics
Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution
View
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing
Clinical Diagnostics
NIPT Market Landscape and Strategy
A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.
View
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy

Featured Team

David Cavanaugh

Founding Partner

Andrew Aijian

Partner

Katie Maloney

Partner

Tina Wang

Senior Project Leader
Data & Platforms

Data & Platforms

See all

Single Cell Analysis Market Report Sixth Edition, 2024-2029

The sixth edition of this report takes a completely updated and comprehensive look at the SCA market. We assess the SCA market across 6 segments and 31 subsegments.
Read More

Next Generation Sequencing (NGS) Market Assessment Trends (2021-2027)

Next Generation Sequencing (NGS)*, having experienced significant stagnation from 2022 to 2024, is poised for a resurgence. We forecast that the ~$6.4B WW NGS manufacturer market (2024) will grow 9% p.a. to reach $8.3B in 2027.
Read More

Spatial and Single-Cell Analysis Market Intelligence Package

Unveil the complexity of cellular analysis with DeciBio's market intelligence package. This report bundle includes our industry-leading reports on the Spatial Biology and Single Cell Analysis markets.
Read More

Oncology Diagnostics Market Intelligence Package

Stay ahead of the curve in the rapidly evolving oncology diagnostics landscape with DeciBio's market intelligence package. This bundle combines our industry-leading reports on two key segments: oncology liquid biopsy and clinical oncology biomarker testing.
Read More
Insights Blog

Related Insights

See all

Digital Health and Informatics | January Round-Up 2025

Read More

GenomeWeb Best Places to Work Winner, 26-50 Employees: DeciBio

Read More

Liquid Biopsy | January Round-Up 2025

Read More

AI / Machine Learning | January Round-Up

Read More
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions